| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.007 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.099 | 0.008 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.008 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.096 | 0.008 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.009 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.092 | 0.009 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |